cetuximab
eli lilly
['crcsm', 'cetuximab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
divarasib plus cetuximab demonstrates promising clinical activity and manageable safety in kras g12c mutant crc #crcsm #aacr23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.